Drug Profile
Research programme: anti-FGF 19 antibody - Genentech
Alternative Names: Anti-FGF 19 antibody; Anti-fibroblast growth factor 19 antibody - GenentechLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Genentech
- Class
- Mechanism of Action Fibroblast growth factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA